Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Pancreas Cancer|Prostate Cancer|Lung Cancer|Colon Cancer|Esophagus Cancer|Liver Cancer|Ovary Cancer|Advanced or Metastatic Treatment-refractory Solid Tumor Malignancies
Interventions: DRUG: NP-G2-044
Sponsor: Novita Pharmaceuticals, Inc.
Collaborators: Translational Drug Development